期刊文献+

趋化因子与糖尿病并发症

原文传递
导出
摘要 本文重点讨论了趋化因子在糖尿病微血管并发症(如糖尿病肾病和糖尿病视网膜病变)和糖尿病大血管病变中表达水平发生的变化,说明了趋化因子及其受体在糖尿病的某些并发症的发病机制中是起着重要作用的。
出处 《国外医学(老年医学分册)》 2005年第5期225-228,共4页 Foreign Medical Sciences(Geriatrics)
  • 相关文献

参考文献18

  • 1许蕾,徐磊,李学礼,王尧.单眼视网膜摘除后鸽左右前脑基因的差异表达[J].生理学报,2001,53(2):155-157. 被引量:14
  • 2Tsou CL, Haskell CA, CharolF. Tumor crcsis factor- alpha- con verting enayme mediates the inducible cleavage of fractalklne. J Biol Chem, 2001; 276:44622-44626.
  • 3Banba N, Nakamura T, Mataumura Met al. Possible relationship of monocyte chemoattractant protein - 1 with diabetic nephropathy. Kidney Int, 2000; 58 (2) : 684-690.
  • 4Wada T, Furuichl K, Sakal N et al. Up- regulation of moncyte chemoattractant protein- 1 in tubulolnterstitlal lesions of human diabetic nephropathy. Kidney Int, 2000;58 (4): 1492-1499.
  • 5Morii T, Fujita H, Narita T et al. Association of monoeyte chemoattractant protein - 1 with renal tubular damage in diabetic nephropathy. Diabetes Compl, 2003; 17(1): 11-15.
  • 6Mezzano S, Aros C, Droguett Aet al. NF- KappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant, 2004; 19(10) : 2505-2512.
  • 7Nakajima K, Tanaka Y, Nomiyama T et al. RANTES promoter genotype is associated with diabetic nephropathy is type 2 diabetic subjects. Diabetes Care, 2003 ; 26(3):892-898.
  • 8Nakajima K, Tanaka Y, Nomiyarna T et al. Chemokine receptor geno- type is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes, 2002;51(1): 238-242.
  • 9Tashiro K, Koyanagi I, Saitoh A et al. Urinary levels of monocyte chemoattractant protein - 1 (MCP - 1) and inter leukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal, 2002; 16(1): 1-4.
  • 10Kikuchi Y, Ikee R, Hemmi N et al. Fractalkine and its receptor CX3CR1 upregulation in streptozotocin - induced diabetic kidneys. Nephron Exp Nephrol, 2004; 97 (1):17-25.

二级参考文献5

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部